Sub-Q Bionics, a medical device company developing next-generation solutions to improve care for patients living with lymphedema, announced the successful close of its $1.5 million pre-seed funding round. The round includes investment from Mayo Clinic and Yeda, the technology transfer company of the Weizmann Institute of Science, as well as several private investors. The Israel Innovation Authority also provided matching funds.